Mitizodone phosphate - Sunshine Lake Pharma
Alternative Names: HEC-113995; HEC113995PA•H2O; Mitizodone phosphate tabletsLatest Information Update: 28 Apr 2023
At a glance
- Originator Sunshine Lake Pharma
- Class Antidepressants; Phosphates
- Mechanism of Action Serotonin receptor agonists; Serotonin uptake inhibitors
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 28 Apr 2023 No recent reports of development identified for phase-I development in Major depressive disorder(In volunteers) in China (PO)
- 28 Aug 2022 No recent reports of development identified for phase-I development in Major depressive disorder(In volunteers) in China (PO, Tablet)
- 30 Jul 2021 Sunshine Lake Pharma plans a phase II/III trial for Major depressive disorder in August 2021 (PO) (NCT04984512)